Although PKR is probably not the only molecular signal at the origin of the brain metabolic anomalies, it may contribute to these abnormal signaling in obese or type 2 diabetes patients together with the toxic accumulation of Abeta in AD brains. This evidence concerns the gene EIF2AK2 and Alzheimer disease.